The Peptide Market in 2026: An Independent Industry Analysis
The Research Peptide Market in 2026: A Landscape Transformed The research peptide market in 2026 bears little resemblance to the market of just two years ago. The three…
Category: Research
Plain-English breakdowns of peptide studies and clinical trials what the data actually shows, and what it doesn’t.
Intranasal vs Injectable Peptide Delivery: What the Evidence Shows
The Core Trade-Off: Bioavailability vs Convenience The debate between intranasal vs injectable peptide delivery has intensified as spray formulation technology has advanced. For most of the research peptide…
BPC-157 Research: What 100+ Published Studies Actually Show
The BPC-157 Evidence Base: Scale and Limitations BPC-157 is the most extensively studied tissue repair peptide in preclinical research, with over 100 published studies spanning three decades. The…
GLP-1 Agonists Explained: Semaglutide, Tirzepatide, and Retatrutide
What GLP-1 Agonists Actually Are TheGLP-1 agonist class has become the most discussed category in both pharmaceutical medicine and peptide research. Semaglutide, tirzepatide, and retatrutide dominate headlines, clinical…
What Happened to Peptide Sciences
The End of an Era: Peptide Sciences Shuts Down Researchers asking what happened to Peptide Sciences are confronting the most significant vendor shutdown in the research peptide market.…
FDA Peptide Reclassification 2026 Explained
What Changed in the FDA’s 2026 Peptide Reclassification The FDA peptide reclassification 2026 decision sent shockwaves through the research community when several popular research peptides were moved back…